Foundry Partners, LLC Myriad Genetics Inc Transaction History

Foundry Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 08, 2020	SELL	$9.78 - $29.53 $101,741 - $307,200	-10,403 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$20.93 - $35.1 $27,795 - $46,612	1,328 Added 14.63%	10,403 $283,000
Q3 2019 Oct 23, 2019	SELL	$22.08 - $47.08 $38,088 - $81,213	-1,725 Reduced 15.97%	9,075 $260,000
Q2 2019 Jul 18, 2019	BUY	$22.67 - $35.0 $31,738 - $49,000	1,400 Added 14.89%	10,800 $300,000
Q1 2019 Apr 22, 2019	BUY	$26.93 - $34.7 $253,142 - $326,180	9,400 New	9,400 $312,000
Q2 2018 Jul 19, 2018	SELL	$27.75 - $40.17 $447,468 - $647,741	-16,125 Closed	0 $0
Q1 2018 May 16, 2018	BUY	$28.83 - $41.01 $184,512 - $262,464	6,400 Added 65.81%	16,125 $476,000
Q4 2017 Jan 25, 2018	SELL	$28.45 - $37.14 $108,821 - $142,060	-3,825 Reduced 28.23%	9,725 $334,000
Q3 2017 Oct 31, 2017	BUY	$24.01 - $36.2 $325,335 - $490,510	13,550	13,550 $490,000

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.23B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Foundry Partners, LLC with notifications on news.